NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Myrtelle Inc.

Myrtelle Inc.

Private
New York City, New YorkHealthcare & Life Scienceshttps://myrtellegtx.com/

Last Round

Early Stage

VC

Jul 2, 2026

Total Funding Raised

$83.67M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Myrtelle Inc. is a biotechnology company that develops and delivers novel gene therapy treatments for devastating disorders of the central nervous system.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

gene therapyrAAVCanavan diseasegenetic medicineoligodendrocyte targetingviral vectorbiotechrare disease treatmentneurodegenerative diseaseAAV capsid platformmyelin-based disordersclinical-stage biotechCDMOorphan drugprecision medicine

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Myrtelle Inc. Comparables

Compare Myrtelle Inc. with similar companies based on industry and business-model similarity.

Myrtelle Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
BridgeBio
83%
Capsida Biotherapeutics
78%
Ajinomoto Co. Inc
78%

Myrtelle Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early Stage VCJul 2, 2026
Series CDec 23, 2025
DebtMar 11, 2025
DebtJun 7, 2024
Series BDec 1, 2022
Series A
Jul 8, 2021

Key People

Founding team and executive leadership

Adrian Stecyk

CEO, Co-Founder

Founding Team

Myrtelle Inc. Investors

Notable investors and investment history

Myrtelle Inc. investors
InvestorRounds
Panacea Venture HealthcareSeries C

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 2, 2026

    $17M raised in early stage VC round.

Myrtelle Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Myrtelle Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Myrtelle Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersNew York City, New York
Employee Range11
Year Founded2020
Last FundingJul 2, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.